Keyphrases
Alzheimer's Disease
100%
Agitation
71%
Citalopram
50%
Apathy
48%
Methylphenidate
48%
Randomized Clinical Trial
41%
Dementia
41%
Convalescent Plasma
34%
Placebo
28%
COVID-19
25%
Neuropsychiatric Symptoms
23%
Clinically Significant
22%
Forced Expiratory Volume in 1 Second (FEV1)
22%
Treatment Trials
21%
Obesity
21%
Alzheimer's Dementia
20%
Randomized Controlled Trial
20%
Lung Function
17%
Quality of Life
17%
Clinical Trials
17%
Multicenter Clinical Trial
15%
Neuropsychiatric Inventory Questionnaire (NPI-Q)
15%
COVID-19 Convalescent Plasma
14%
Long-term Oxygen Therapy
14%
Chronic Obstructive Pulmonary Disease
14%
Fall Reduction
13%
Falls in Older Adults
13%
Early Parkinson's Disease
13%
Sex Differences
13%
Poorly Controlled Asthma
13%
Deep Brain Stimulation
13%
Vitamin D Supplementation
13%
Early Outpatient Treatment
13%
Escitalopram
13%
Confidence Interval
13%
Symptom Onset
13%
Optimal Dose
11%
Hospitalization
10%
Airway Obstruction
10%
Convalescent Plasma Therapy
10%
Forced Vital Capacity
10%
Psychosocial Intervention
9%
Hypoxemia
9%
Hazard Ratio
9%
Transfusion
9%
Patient Global Impression of Change
9%
Asthma Symptoms
9%
Randomized Trial
9%
Adverse Events
9%
Neurobehavior
8%
Medicine and Dentistry
Clinical Trial
49%
Alzheimer's Disease
45%
Chronic Obstructive Pulmonary Disease
42%
Methylphenidate
41%
Symptom
36%
Placebo
33%
Randomized Clinical Trial
29%
Asthma
28%
Vitamin D
27%
Emphysema
23%
Uveitis
20%
Steroid Treatment
20%
Randomized Controlled Trial
20%
Quality of Life
20%
Neuropsychiatric Inventory
17%
COVID-19
16%
Patient with Alzheimer's Disease
15%
Adverse Event
14%
Patient Safety
13%
Outpatient
13%
Convalescence
13%
Visual Acuity
12%
Forced Expiratory Volume
10%
Reproducibility
10%
Tau
10%
Colecalciferol
10%
Spirometry
9%
Six Minute Walk Test
9%
Fluocinolone Acetonide
9%
Cognitive Change
9%
Drug Therapy
9%
Body Mass Index
8%
Supplementation
8%
Infection
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Best Corrected Visual Acuity
8%
Frailty
8%
Physical Performance
8%
Adaptive Response
8%
Patient with Asthma
8%
Cerebrospinal Fluid
8%
Forced Vital Capacity
8%
Hypoxemia
8%
Internal Medicine
8%
Arm
8%
Disease
8%
Hazard Ratio
7%
Mild Cognitive Impairment
7%
Weakness
7%
Implant
7%
